Jian Jiang

Jian Jiang


Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
15 April 2022 in Biochemical Pharmacology
Verified
Journal Article
Closed access
RSRong-Jia Shi
Rong-Jia Shi
HFHua-Yang Fan
Hua-Yang Fan
XYXiang-Hua Yu
Xiang-Hua Yu
YTYa-Ling Tang
Ya-Ling Tang
JJJian Jiang
Jian Jiang
XLXinhua Liang
Xinhua Liang

27 August 2022 in Cancers
Verified
Journal Article
Open access
PDF file
HWHaofan Wang
Haofan Wang
JJJian Jiang
Jian Jiang
JWJia-Shun Wu
Jia-Shun Wu
MZMei Zhang
Mei Zhang
XPXin Pang
Xin Pang
XLXinhua Liang
Xinhua Liang
Purpose: To study the role of target genes with aberrant DNA methylation in HPV+ HNSCC. Methods: A HumanMethylation450 BeadChip array (Illumina) was used to identify differentially methylated genes. CCK-8, flow cytometry, wound healing, and cell invasion assays were conducted to analyze the biological roles of PRKCZ. Western blot, qRT-PCR, immunohistochemistry, and animal studies were performed to explore the mechanisms underlying the functions of PRKCZ. Results: We selected PRKCZ, which is associated with HPV infection, as our target gene. PRKCZ was hypermethylated in HPV+ HNSCC patients, and PRKCZ methylation status was negatively related to the pathological grading of HNSCC patients. Silencing PRKCZ inhibited the malignant capacity of HPV+ HNSCC cells. Mechanistically, HPV might promote DNMT1 expression via E6 to increase PRKCZ methylation. Cdc42 was required for the PRKCZ-mediated mechanism of action, contributing to the occurrence of epithelial-mesenchymal transition (EMT) in HPV+ HNSCC cells. In addition, blocking PRKCZ delayed tumor growth in HPV16-E6/E7 transgenic mice. Cdc42 expression was decreased, whereas E-cadherin levels increased. Conclusion: We suggest that PRKCZ hypermethylation induces EMT via Cdc42 to act as a potent tumor promoter in HPV+ HNSCC.


1 September 2024
Verified
Journal Article
Closed access
XLXiao Luo
Xiao Luo
JJJian Jiang
Jian Jiang
SGShan Gao
Shan Gao
MDMingliang Dou
Mingliang Dou
JLJiali Liao
Jiali Liao